Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/2344
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ramsay, Rona R. | |
dc.contributor.author | De Deurwaerdere, Philippe | |
dc.date.accessioned | 2015-04-13T05:22:37Z | |
dc.date.available | 2015-04-13T05:22:37Z | |
dc.date.issued | 2014 | |
dc.identifier.citation | Xjenza. 2014, Vol.2(2), p. 44-47 | en_GB |
dc.identifier.uri | https://www.um.edu.mt/library/oar//handle/123456789/2344 | |
dc.description.abstract | The third EU COST Action CM1103 “Structure-based drug design for diagnosis and treatment of neurological diseases: dissecting and modulating complex function in the monoaminergic systems of the brain” Annual Conference entitled “Neuropathology and Neuropharmacology of Monoaminergic Systems” was hosted by the University of Bordeaux, France on 8-10 October 2014. The conference, organized by Prof. De Deurwaerdère, was supported by COST (European Cooperation in Science and Technology) and LABEX (LABEX Brain, University of Bordeaux). The program took the form of a three-day meeting, comprising a series of French and international invited talks and breakout sessions designed to identify key gaps in current knowledge and potential future research questions. The aims of this Conference were two-fold: 1. To identify the current state-of-the-art in the understanding of the pathological mechanisms that contribute to different neuropsychiatric disorders, and to what extent, monoamines a multi-target drugs and/or other interventions might prevent these changes. 2. To identify specific areas of research where information is sparse but which are likely to yield data that will impact on future strategies to treat neurodegenerative disorders. | en_GB |
dc.language.iso | en | en_GB |
dc.publisher | Malta Chamber of Scientists | en_GB |
dc.rights | info:eu-repo/semantics/openAccess | en_GB |
dc.subject | Nervous system -- Diseases | en_GB |
dc.subject | Amines -- Congresses | en_GB |
dc.subject | Mental illness -- Pathophysiology | en_GB |
dc.subject | Nervous System -- Pathology | en_GB |
dc.subject | Mental illness -- Treatment | en_GB |
dc.title | Meeting report : Neuropathology and Neuropharmacology of Monoaminergic systems | en_GB |
dc.type | article | en_GB |
dc.rights.holder | The copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder. | en_GB |
dc.description.reviewed | peer-reviewed | en_GB |
dc.identifier.doi | 10.7423/XJENZA.2014.2.07 | |
Appears in Collections: | Xjenza, 2014, Volume 2, Issue 2 Xjenza, 2014, Volume 2, Issue 2 Xjenza, 2017, Volume 5, Special Issue: COST 2017 Xjenza, 2017, Volume 5, Special Issue: COST 2017 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Neuropathology and Neuropharmacology of Monoaminergic Systems.pdf | 5.59 MB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.